Peripheral T-cell Lymphoma clinical trials
Access comprehensive clinical trial information for Peripheral T-cell Lymphoma through Pure Global AI's free database. This collection includes 40 clinical trials across multiple phases including Phase 2, Phase 1, Phase 3. Currently, 11 trials are actively recruiting participants.
Research for Peripheral T-cell Lymphoma is being conducted in China, Japan, United States of America and 7+ other countries. Leading sponsors include Ruijin Hospital and Acrotech Biopharma Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 40 clinical trials studying Peripheral T-cell Lymphoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Ruijin Hospital, Acrotech Biopharma Inc., Mingzhi Zhang, among others.